Ken Cacciatore
Stock Analyst at TD Cowen
(0)
# 4970
Out of 5,329 analysts
17
Total ratings
27.27%
Success rate
-31.47%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 65 50 | 15.25 | 227.87% | 2 | Aug 9, 2023 | |
BHC Bausch Health Compan... | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 16, 2023 | |
TAK Takeda Pharmaceutica... | Maintains: Outperform | 30 20 | 15.29 | 30.8% | 4 | May 16, 2023 | |
ISEE IVERIC bio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 8, 2023 | |
SCPH scPharmaceuticals | Initiates Coverage On: Outperform | 25 | 2.57 | 872.76% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 11.78 | 197.11% | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 3.75 | 1233.33% | 1 | Jul 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 3.64 | 1273.63% | 1 | Oct 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 23.83 | 88.84% | 1 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 460 | 11.37 | 3945.73% | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 375 | 9.41 | 3885.12% | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 22, 2017 |